From: A retrospective clinical and microbial analysis of 32 patients with bilomas
Therapy | Number of patients during initial hospital stay | Proportion of patients (%) during initial hospital stay | Number of patients during clinical follow-up | Proportion of patients (%) during clinical follow-up |
---|---|---|---|---|
Wait-and-see approach | ||||
No intervention | 7 | 21.9% | 6 | 18.8% |
Single modal therapy | ||||
CT | 1 | 3.1% | 2 | 6.3% |
ERC | 5 | 15.6% | 5 | 15.6% |
PTCD | 1 | 3.1% | 1 | 3.1% |
Multimodal therapy | ||||
ERC, SGP | 3 | 9.4% | 2 | 6.3% |
ERC, CT | 7 | 21.9% | 5 | 15.6% |
ERC, SGP, CT | 1 | 3.1% | 1 | 3.1% |
PTCD, SGP | 2 | 6.3% | 2 | 6.3% |
PTCD, CT | 1 | 3.1% | 1 | 3.1% |
Rendezvous, SGP | 2 | 6.3% | 1 | 3.1% |
Rendezvous, SGP, CT | 0 | 0.0% | 1 | 3.1% |
ERC, PTCD (no rendezvous) | 1 | 3.1% | 1 | 3.1% |
ERC, PTCD, CT | 1 | 3.1% | 2 | 6.3% |
ERC, SGP, CT, PTCD | 0 | 0.0% | 1 | 3.1% |
Surgery | ||||
Biloma abscess resection | 0 | 0.0% | 1 | 3.1% |